Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies

Fertility and Sterility

Volumn 102, Issue 2, 2014, Pages

  Meirow, Dror ^a   Raanani, Hila ^a   Maman, Ettie ^a   Paluch Shimon, Shani ^a   Shapira, Moran ^a   Cohen, Yoram ^a   Kuchuk, Irena ^a   Hourvitz, Ariel ^a   Levron, Jacob ^a   Mozer Mendel, Michal ^a   Brengauz, Masha ^a   Biderman, Hana ^a   Manela, Daphna ^a   Catane, Rephael ^a   Dor, Jehoshua ^a   Orvieto, Raoul ^a   Kaufman, Bella ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

breast cancer; controlled ovarian hyperstimulation; fertility preservation; IVF; tamoxifen

Indexed keywords

ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED OVARIAN HYPERSTIMULATION; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DRUG EFFICACY; DRUG SAFETY; ESTROGEN BLOOD LEVEL; ESTROGEN RELEASE; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; MULTIPLE DRUG DOSE; OOCYTE; OVARY HYPERSTIMULATION; PATIENT HISTORY OF CHEMOTHERAPY; PATIENT SAFETY; PREMENOPAUSE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; TERTIARY CARE CENTER;

BREAST CANCER; CONTROLLED OVARIAN HYPERSTIMULATION; FERTILITY PRESERVATION; IVF; TAMOXIFEN;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CRYOPRESERVATION; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; FERTILITY AGENTS, FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREMENOPAUSE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TAMOXIFEN; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905493782     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.05.017     Document Type: Article

References (63)

1. C. DeSantis, J. Ma, L. Bryan, and A. Jemal Breast cancer statistics, 2013 CA Cancer J Clin 64 2014 52 62
2. J.A. Martin, B.E. Hamilton, P.D. Sutton, S.J. Ventura, T.J. Mathews, and M.J. Osterman Births: final data for 2008 Natl Vital Stat Rep 59 2010 3 71
3. M. Sant, C. Allemani, F. Berrino, M.P. Coleman, T. Aareleid, and G. Chaplain et al. Breast carcinoma survival in Europe and the United States Cancer 100 2004 715 722
4. H.A. Azim Jr., S. Michiels, P.L. Bedard, S.K. Singhal, C. Criscitiello, and M. Ignatiadis et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling Clin Cancer Res 18 2012 1341 1351
5. G. Cancello, P. Maisonneuve, N. Rotmensz, G. Viale, M.G. Mastropasqua, and G. Pruneri et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer Ann Oncol 21 2010 1974 1981
6. K.A. Hill, T. Nadler, R. Mandel, S. Burlein-Hall, C. Librach, and K. Glass et al. Experience of young women diagnosed with breast cancer who undergo fertility preservation consultation Clin Breast Cancer 12 2012 127 132
7. K.J. Ruddy, S. Gelber, E.S. Ginsburg, L. Schapira, M.E. Abusief, and M.E. Meyer et al. Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls Menopause 18 2011 105 108
8. B.Y. Kong, R.M. Skory, and T.K. Woodruff Creating a continuum of care: integrating obstetricians and gynecologists in the care of young cancer patients Clin Obstet Gynecol 54 2011 619 632
9. M. Scanlon, A. Blaes, M. Geller, N.S. Majhail, B. Lindgren, and T. Haddad Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer J Cancer 3 2012 217 225
10. D. Meirow Epidemiology and infertility in cancer patients T. Tulandi, R. Gosden, Preservation of fertility 2004 Taylor and Francis London, UK 21 38
11. R.M. Anchan, and E.S. Ginsburg Fertility concerns and preservation in younger women with breast cancer Crit Rev Oncol Hematol 74 2010 175 192
12. D. Meirow, H. Biederman, R.A. Anderson, and W.H. Wallace Toxicity of chemotherapy and radiation on female reproduction Clin Obstet Gynecol 53 2010 727 739
13. M. Hickey, M. Peate, C.M. Saunders, and M. Friedlander Breast cancer in young women and its impact on reproductive function Hum Reprod Update 15 2009 323 339
14. A.H. Partridge, K.J. Ruddy, S. Gelber, L. Schapira, M. Abusief, and M. Meyer et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer Fertil Steril 94 2010 638 644
15. S.S. Kim, J. Donnez, P. Barri, A. Pellicer, P. Patrizio, and Z. Rosenwaks et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer J Assist Reprod Genet 29 2012 465 468
16. K.A. Rodriguez-Wallberg, and K. Oktay Options on fertility preservation in female cancer patients Cancer Treat Rev 38 2012 354 361
17. R.B. Quintero, A. Helmer, J.Q. Huang, and L.M. Westphal Ovarian stimulation for fertility preservation in patients with cancer Fertil Steril 93 2010 865 868
18. A.H. Partridge, O. Pagani, O. Abulkhair, S. Aebi, F. Amant, and H.A. Azim et al. First international consensus guidelines for breast cancer in young women (BCY1) Breast 2014 10.1016/j.breast.2014.03.011 [Epub ahead of print]
19. G.M. Calaf Susceptibility of human breast epithelial cells in vitro to hormones and drugs Int J Oncol 28 2006 285 295
20. S.C. Aitken, and M.E. Lippman Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture Cancer Res 42 1982 1727 1735
21. M. Colleoni, S. Gelber, A. Goldhirsch, S. Aebi, M. Castiglione-Gertsch, and K.N. Price et al. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93 J Clin Oncol 24 2006 1332 1341
22. J. Cuzick, T. Powles, U. Veronesi, J. Forbes, R. Edwards, and S. Ashley et al. Overview of the main outcomes in breast-cancer prevention trials Lancet 361 2003 296 300
23. S. Hartmann, T. Reimer, and B. Gerber Management of early invasive breast cancer in very young women (<35 years) Clin Breast Cancer 11 2011 196 203
24. I. Cohen, A. Figer, R. Tepper, J. Shapira, M.M. Altaras, and D. Yigael et al. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients Gynecol Oncol 72 1999 202 207
25. A. Shulman, I. Cohen, M.M. Altaras, R. Maymon, I. Ben-Nun, and R. Tepper et al. Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer Hum Reprod 9 1994 1427 1429
26. A.W. Loren, P.B. Mangu, L.N. Beck, L. Brennan, A.J. Magdalinski, and A.H. Partridge et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol 31 2013 2500 2510
27. J.A. Petrek, M.J. Naughton, L.D. Case, E.D. Paskett, E.Z. Naftalis, and S.E. Singletary et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study J Clin Oncol 24 2006 1045 1051
28. S.E. Barton, S.A. Missmer, K.F. Berry, and E.S. Ginsburg Female cancer survivors are low responders and have reduced success compared with other patients undergoing assisted reproductive technologies Fertil Steril 97 2012 381 386
29. O. Pagani, A. Partridge, L. Korde, S. Badve, J. Bartlett, and K. Albain et al. Pregnancy after breast cancer: if you wish, ma'am Breast Cancer Res Treat 129 2011 309 317
30. H.A. Azim Jr., N. Kroman, M. Paesmans, S. Gelber, N. Rotmensz, and L. Ameye et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study J Clin Oncol 31 2013 73 79
31. N. Andrieu, D.E. Goldgar, D.F. Easton, M. Rookus, R. Brohet, and A.C. Antoniou et al. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) J Natl Cancer Inst 98 2006 535 544
32. S. Reinmuth, A.K. Liebeskind, L. Wickmann, A. Bockelbrink, T. Keil, and G. Henze et al. Having children after surviving cancer in childhood or adolescence - results of a Berlin survey Klin Padiatr 220 2008 159 165
33. S.J. Lee, L.R. Schover, A.H. Partridge, P. Patrizio, W.H. Wallace, and K. Hagerty et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 24 2006 2917 2931
34. J. Domingo, V. Guillen, Y. Ayllon, M. Martinez, E. Munoz, and A. Pellicer et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment Fertil Steril 97 2012 930 934
35. S. Friedler, O. Koc, Y. Gidoni, A. Raziel, and R. Ron-El Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis Fertil Steril 97 2012 125 133
36. K. Chung, J. Donnez, E. Ginsburg, and D. Meirow Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients Fertil Steril 99 2013 1534 1542
37. J.A. Garcia-Velasco, J. Domingo, A. Cobo, M. Martínez, L. Carmona, and A. Pellicer Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications Fertil Steril 99 2013 1994 1999
38. Mature oocyte cryopreservation: a guideline Fertil Steril 99 2013 37 43
39. S. Cold, M. During, M. Ewertz, A. Knoop, and S. Moller Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG) Br J Cancer 93 2005 627 632
40. C. Lohrisch, C. Paltiel, K. Gelmon, C. Speers, S. Taylor, and J. Barnett et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer J Clin Oncol 24 2006 4888 4894
41. I. Cohen, D.J. Rosen, M. Altaras, Y. Beyth, J. Shapira, and D. Yigael Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth Br J Cancer 69 1994 620 621
42. G.V. Groom, and K. Griffiths Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women J Endocrinol 70 1976 421 428
43. V.C. Jordan, N.F. Fritz, S. Langan-Fahey, M. Thompson, and D.C. Tormey Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent J Natl Cancer Inst 83 1991 1488 1491
44. C.K. Osborne, R. Schiff, S.A. Fuqua, and J. Shou Estrogen receptor: current understanding of its activation and modulation Clin Cancer Res 7 2001 4338s 4342s disc. 411s-2s
45. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
46. S. Aebi, T. Davidson, G. Gruber, and F. Cardoso Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 22 Suppl 6 2011 vi12 vi24
47. C. Davies, J. Godwin, R. Gray, M. Clarke, D. Cutter, and S. Darby et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 378 2011 771 784
48. A. Goldhirsch, E.P. Winer, A.S. Coates, R.D. Gelber, M. Piccart-Gebhart, and B. Thurlimann et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013 Ann Oncol 24 2013 2206 2223
49. K. Oktay, J.Y. Kim, D. Barad, and S.N. Babayev Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks J Clin Oncol 28 2010 240 244
50. K. Oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen Hum Reprod 18 2003 90 95
51. K. Oktay, A. Hourvitz, G. Sahin, O. Oktem, B. Safro, and A. Cil et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy J Clin Endocrinol Metab 91 2006 3885 3890
52. K.A. Rodriguez-Wallberg, and K. Oktay Fertility preservation in women with breast cancer Clin Obstet Gynecol 53 2010 753 762
53. A. Revelli, E. Porcu, P.E. Levi Setti, L. Delle Piane, D.F. Merlo, and P. Anserini Is Letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? Gynecol Endocrinol 29 2013 993 996
54. R.C. Chian, P.S. Uzelac, and G. Nargund In vitro maturation of human immature oocytes for fertility preservation Fertil Steril 99 2013 1173 1181
55. S. Roesner, M. Von Wolff, I. Eberhardt, P. Beuter-Winkler, B. Toth, and T. Strowitzki In vitro maturation: a five-year experience Acta Obstet Gynecol Scand 91 2012 22 27
56. R.C. Chian, L. Gilbert, J.Y. Huang, E. Demirtas, H. Holzer, and A. Benjamin et al. Live birth after vitrification of in vitro matured human oocytes Fertil Steril 91 2009 372 376
57. J. Donnez, M.M. Dolmans, D. Demylle, P. Jadoul, C. Pirard, and J. Squifflet et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue Lancet 364 2004 1405 1410
58. D. Meirow, J. Levron, T. Eldar-Geva, I. Hardan, E. Fridman, and Y. Zalel et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy N Engl J Med 353 2005 318 321
59. R.A. Anderson, W.H. Wallace, and D.T. Baird Ovarian cryopreservation for fertility preservation: indications and outcomes Reproduction 136 2008 681 689
60. D. Meirow, I. Hardan, J. Dor, E. Fridman, S. Elizur, and H. Ra'anani et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients Hum Reprod 23 2008 1007 1013
61. M. Sanchez-Serrano, E. Novella-Maestre, E. Rosello-Sastre, N. Camarasa, J. Teruel, and A. Pellicer Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation Hum Reprod 24 2009 2238 2243
62. J. Donnez, S. Silber, C.Y. Andersen, I. Demeestere, P. Piver, and D. Meirow et al. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births Ann Med 43 2011 437 450
63. J. Donnez, M.M. Dolmans, A. Pellicer, C. Diaz-Garcia, M. Sanchez Serrano, and K.T. Schmidt et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation Fertil Steril 99 2013 1503 1513